Alnylam Pharmaceuticals, Inc. - Common Stock (ALNY)

CUSIP: 02043Q107

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 7 signals
Share change
+3,702,084
Put/Call ratio
204%
SEC-reported price per share
$246.74
Number of holders
399
Value change
+$865,266,094
Number of buys
202
Open additional details 1 more signal available
Number of sells
203
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
133,985,952

Security key

02043Q107

Report period

Q3 2026

Institutions

399

Top holders

10

Ownership snapshot

Top reported holders of ALNY - Alnylam Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Capital World Investors
Disclosed value leader
FMR LLC
Comparable rows
5/15
Latest evidence
30 Sep 2026
13D/G 13F Lead comparable stake: 10% 10 rows are not safely comparable across share classes. 13D/G row: Capital World Investors Showing 1-6 of 15 holder rows.

Quick read

Capital World Investors leads the comparable SEC ownership view at 10%.

5 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Capital World Investors's linked filing trail.
Comparable ownership Top 5
Capital World Investors 10%
FMR LLC 9.5%
Capital Research Global Investors 7.1%
VANGUARD CAPITAL MANAGEMENT LLC 5.4%
VANGUARD PORTFOLIO MANAGEMENT LLC 5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Capital World Investors
13D/G 13F
Company
10%
Reported 13D/G · 30 Sep 2026
$3,438,208,153
13,934,539 shares
+$744,597,168 30 Sep 2026
FMR LLC
13F 13D/G
Company
9.5%
Reported 13D/G · 30 Sep 2026
$4,522,663,249
15,023,962 shares
— 30 Jun 2026
Capital Research Global Investors
13D/G 13F
Company
7.1%
Reported 13D/G · 31 Mar 2026
$3,153,903,273
9,471,181 shares
+$833,388,444 31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC
13D/G 13F
Vanguard Capital Management · Company
5.4%
Reported 13D/G · 31 Mar 2026
$2,350,677,826
7,104,536 shares
$0 31 Mar 2026
VANGUARD PORTFOLIO MANAGEMENT LLC
13F 13D/G
Company · Vanguard Portfolio Management
5%
Reported 13D/G · 30 Sep 2026
$1,968,251,542
6,538,390 shares
— 30 Jun 2026
BlackRock, Inc.
13F
Company
13F
—
denominator unverified
$3,283,537,489
10,907,675 shares
— 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
399
Shares
52,577,509
Rows available
399
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
792
Q3 2026 holders
399
Holder diff
-393
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .